PharmaWatch: Updates Impacting the Workers’ Compensation Industry

Pharmacist looks at and holds small box in left hand

Timely clinical updates and thought leadership on new drug and indication approvals, discontinuation and withdrawals, new dosages or formulations of existing products and generics introduced to the market. For questions regarding new updates, please email clinical@myMatrixx.com.

News and Updates

Female pharmacist at counter smiling

ODG Formulary Updates for “Y” and “N” Drugs

Effective July 26, 2024, ODG by MCG is updating Appendix A − its drug formulary – with the following medication edits to both the preferred, first-line “Y” drugs, and drugs that are not recommended as a first-line treatment known as “N” drugs.
Learn more
Male Pharmacist

Q2 2024 New Drug Report (April-June)

Read our new Q2 2024 (January through March) pipeline report that features new drug approvals, new generics, withdrawals and discontinuations of certain products, as well as near-term pipeline products and patent expirations.
Learn more